Keryx's stock is traded on
the Nasdaq
National Market and the Alternative
Investment Market (AIM) of the London Stock Exchange.
Contact
Information:
Keryx Biopharmaceuticals, Inc.
Beit Hadarim
7 Hartom St.
Har Hotzvim
Jerusalem 91236
Tel: +972-2-541-3500
Fax: +972-2-541-3501
Contact:
Ron Bentsur
Investor Relations
bentsur@keryx.com
Bob
Gallahue
Chief Financial Officer
bgallahue@keryxus.com
Home
Page:
http://www.keryx.com
Shareholder Information:
|
Exchange
|
Symbol
|
|
NASDAQ
|
|
|
AIM
|
|
SEC Filings:
Registration
Statement on S-1, July 27, 2000
Final
Prospectus (Form 424B1), July 28, 2000
Form
10Q, September 11, 2000
|
